As a high-tech enterprise dedicated to transforming life scientific and industrial outcomes into its core business, YHZK BIOPHARM is committed to developing new application scenarios and combining its business with advanced digital technologies to create a globally leading cellular industrial brand that covers all elements, the whole life cycle and the industry chain by virtue of its own industrialized cellular manufacturing capacity. The enterprise's mission is to empower its service capabilities and make its contribution to the industrial ecosystem.

YHZK BIOPHARM specializes in the technological development and innovative applications of biomedical sections, biopharmaceuticals, and cells. It has established a set of mature and perfect practice standards from the levels of industry, academia, research, application and regulation for CDMO, a new cellular drug. Furthermore, YHZK is devoted to becoming a top biotech company in China and even worldwide for its cellular research, cellular drug development and disease treatment with its capital advantage.